MedPath

Cochlear Implant Low Power Strategy

Not Applicable
Completed
Conditions
Hearing Loss
Interventions
Device: MP3000 sound coding strategy or ACE strategy with lower stimulation
Registration Number
NCT02879539
Lead Sponsor
The Hearing Cooperative Research Centre
Brief Summary

Reducing power consumption in the cochlear implant is crucial to the development of future smaller sound processors. The commercial MP3000 sound coding strategy has been shown to be more efficient in power consumption to the standard ACE strategy. However in order to develop smaller sound processors, further battery life power savings are required. The aim of this study is to evaluate three experimental sets of MP3000 parameter sets, compared against the default ACE program. In the background for each of the four strategies, experimental noise reduction programs (SpatialNR and NR3) will also be in use. In an additional phase of the study, low stimulation rate ACE programs will also be evaluated against the default stimulation rate.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32
Inclusion Criteria
  1. Adult (>18 years) cochlear implant recipients
  2. Implanted with the CI500, CI24RE and Nucleus 24 Series and CI422 cochlear implants.
  3. User of commercially available Freedom, CP810 or CP900 series sound processor
  4. User of the ACE strategy or MP3000 strategy
  5. At least 3 months experience with the cochlear implant
  6. Native speaker in the language used to assess speech perception performance
  7. Willingness to participate in and to comply with all requirements of the protocol
Exclusion Criteria
  1. Additional handicaps that would prevent participation in evaluations
  2. Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the procedure and investigational device

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
MP3000-ACE strategyMP3000 sound coding strategy or ACE strategy with lower stimulationMP3000 sound coding strategy or ACE strategy with lower stimulation rate
Primary Outcome Measures
NameTimeMethod
Word recognition scores in quietTesting over 18 weeks

Word recognition scores in quiet for i) MP3000 strategy compared to default ACE strategy and ii) lower rate stimulation for ACE strategy

Sentence recognition scores in quietTesting over 18 weeks

Sentence recognition scores in quiet for i) MP3000 strategy compared to ACE strategy and ii) lower rate stimulation for ACE strategy

Secondary Outcome Measures
NameTimeMethod
Fundamental frequency (F0) discriminationTesting over 18 weeks

F0 discrimination for MP3000 strategy compared to the ACE baseline

Speech intelligibility and helpfulness subjective ratingsTesting over 18 weeks

For MP3000 strategy compared to the default ACE baseline

Sentence in noise scoresTesting over 18 weeks

Comparison of MP3000 program with Spatial NR and NR3 enabled versus disabled.

Trial Locations

Locations (1)

The HEARing CRC

🇦🇺

Melbourne, Victoria, Australia

© Copyright 2025. All Rights Reserved by MedPath